HDAC9 and thyroid gland carcinoma: We recently demonstrated that combination of the HDAC inhibitor SAHA with inhibitors of the MAP kinase and PI3K/Akt pathways could induce robust and synergistic expression of NIS and radioiodine uptake in thyroid cancer cells [13].